Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival.
Nan LiKai YuZhong LinDingyuan ZengPublished in: Journal of oncology (2022)
The study developed a novel immune subtyping system and an 11-gene prognostic model of prostate cancer, which could guide personalized treatment and immunotherapy for patients with prostate cancer.